Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres

Journal of Cell Science

Volumn 119, Issue 9, 2006, Pages 1864-1875

  Gregor, Martin ^a   Zeöld, Aniko ^a   Oehler, Susanne ^a   Marobela, Kerstin Andrä ^a   Fuchs, Peter ^a   Weigel, Günter ^b   Hardie, D Graham ^c   Wiche, Gerhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

AMPK regulation; Cytolinker proteins; Cytoskeleton; Myoblast differentiation; Z lines

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOENZYME; PLECTIN; THREONINE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL DIFFERENTIATION; CELL ENERGY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOARCHITECTURE; DATA ANALYSIS; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBUNIT; HOMEOSTASIS; IN VITRO STUDY; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; MICE; MICE, KNOCKOUT; MUSCLE FIBERS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PLECTIN; PROTEIN BINDING; PROTEIN SUBUNITS; RATS; RECOMBINANT FUSION PROTEINS;

ANIMALIA;

EID: 33744541891     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02891     Document Type: Article

References (65)

1. Adams, J., Chen, Z. P., Van Denderen, B. J., Morton, C. J., Parker, M. W., Witters, L. A., Stapleton, D. and Kemp, B. E. (2004). Intrasteric control of AMPK via the gammnal subunit AMP allosteric regulatory site. Protein Sci. 13, 155-165.
2. Al-Hakim, A. K., Goransson, O., Deak, M., Toth, R., Campbell, D. G., Morrice, N. A., Prescott, A. R. and Alessi, D. R. (2005). 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J. Cell Sci. 118, 5661-5673.
3. Andrä, K., Lassmann, H., Bittner, R., Shorny, S., Fässler, R., Propst, F. and Wiche, G. (1997). Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev. 11, 3143-3156.
4. Andrä, K., Nikolic, B., Stöcher, M., Drenckhahn, D. and Wiche, G. (1998). Not just scaffolding:plectin regulates actin dynamics in cultured cells. Genes Dev. 12, 3442-3451.
5. Atkinson, D. E. (1968). The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7, 4030-4034.
6. Baeza-Raja, B. and Munoz-Canoves, P. (2004). p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol. Biol. Cell 15, 2013-2026.
7. Blanco-Bose, W. E., Yao, C. C., Kramer, R. H. and Blau, H. M. (2001). Purification of mouse primary myoblasts based on alpha 7 integrin expression. Exp. Cell Res. 265, 212-220.
8. Carling, D. (2004). The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem. Sci. 29, 18-24.
9. Carling, D., Clarke, P. R., Zammit, V. A. and Hardie, D. G. (1989). Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur. J. Biochem. 186, 129-136.
10. Chen, Z., Heierhorst, J., Mann, R. J., Mitchelhill, K. I., Michell, B. J., Witters, L. A., Lynch, G. S., Kemp, B. E. and Stapleton, D. (1999). Expression of the AMP-activated protein kinase betal and beta2 subunits in skeletal muscle. FEBS Lett. 460, 343-348.
11. Cheung, P, C., Salt, I. P., Davies, S. F., Hardie, D. G. and Carling, D. (2000). Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346, 659-669.
12. Crute, B. E., Seefeld, K., Gamble, J., Kemp, B. E. and Witters, L. A. (1998). Functional domains of the alphal catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273, 35347-35354.
13. Davies, S. P., Helps, N. R., Cohen, F. T. and Hardie, D. G. (1995). 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Len. 377, 421-425.
14. Durante, P. E., Mustard, K. J., Park, S. H., Winder, W. W. and Hardie, D. G. (2002). Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am. J. Physiol. Endocrinol. Metab. 283, E178-E186.
15. Fleming, I., Fisslthaler, B., Dixit, M. and Busse, R. (2005). Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J. Cell Sci. 118, 4103-4111.
16. Foisner, R., Feldman, B., Sander, L., Seifert, G., Artlieb, U. and Wiche, G. (1994). A panel of monoclonal antibodies to rat plectin: distinction by epitope mapping and immunoreactivity with different tissues and cell lines. Acta Histochem. 96, 421-438.
17. Gache, Y., Chavanas, S., Lacour, J. P., Wiche, G., Owaribe, K., Meneguzzi, G. and Ortonne, J. F. (1996). Defective expression of plectin/ HD1 in epidermolysis bullosa simplex with muscular dystrophy. J. Clin. Invest. 97, 2289-2298.
18. Hamilton, S. R., Stapleton, D., O'Donnell, J. B., Jr, Kong, J. T., Dalal, S. R., Kemp, B. E. and Witters, L. A. (2001). An activating mutation in the gammal subunit of the AMP-activated protein kinase. FEBS Lett. 500, 163-168.
19. Hardie, D. G. and Carling, D. (1997). The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J. Biochem. 246, 259-273.
20. Hardie, D. G. and Hawley, S. A. (2001). AMP-activated protein kinase: the energy charge hypothesis revisited. BioEssays 23, 1112-1119.
21. Hardie, D. G., Carling, D. and Carlson, M. (1998). The AMP-activated/ SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821-855.
22. Hardie, D. G., Salt, I. P., Hawley, S. A. and Davies, S. P. (1999). AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338, 717-722.
23. Hardie, D. G., Scott, J. W., Pan, D. A. and Hudson, E. R. (2003). Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546, 113-120.
24. Hawley, S. A., Selbert, M. A., Goldstein, E. G., Edelman, A. M., Carling, D. and Hardie, D. G. (1995). 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 270, 27186-27191.
25. Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Makela, T. P., Alessi, D. R. and Hardie, D. G. (2003). Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28.
26. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T. and Weinberg, R. A. (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
27. Janmey, P. A. (1998). The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol. Rep. 78, 763-781.
28. Kemp, B. E. (2004). Bateman domains and adenosine derivatives form a binding contract. J. Clin. Invest. 113, 182-184.
29. Larsen, A. K., Moller, M. T., Blankson, H., Samari, H. R., Holden, L. and Seglen, P. O. (2002). Naringin-sensitive phosphorylation of plectin, a cytoskeletal cross-linking protein, in isolated rat hepatocytes. J. Biol. Chem. 277, 34826-34835.
30. Lunter, P. C. and Wiche, G. (2002). Direct binding of plectin to Fer kinase and negative regulation of its catalytic activity. Biochem. Biophys. Res. Commun. 296, 904-910.
31. Mahlapuu, M., Johansson, C., Lindgren, K., Hjalm, G., Barnes, B. R., Krook, A., Zierath, J. R., Andersson, L. and Marklund, S. (2004). Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 286, E194-E200.
32. McLean, W. H., Pulkkinen, L., Smith, R J., Rugg, E. L., Lane, E. B., Bullrich, F., Burgeson, R. E., Amano, S., Hudson, D. L., Owaribe, K. et al. (1996). Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 10, 1724-1735.
33. Merrill, G. F., Kurth, E. J., Hardie, D. G. and Winder, W. W. (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273, E1107-E1112.
34. Mitchelhill, K. I., Stapleton, D., Gao, G., House, C., Michell, B., Katsis, F., Witters, L. A. and Kemp, B. E. (1994). Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem. 269, 2361-2364.
35. Morgenstern, J. P. and Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
36. Mu, J., Brozinick, J. T., Jr, Valladares, O., Bucan, M. and Birnbaum, M. J. (2001). A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7, 1085-1094.
37. Neumann, D., Schlattner, U. and Wallimana, T. (2003a). A molecular approach to the concerted action of kinases involved in energy homoeostasis. Biochem. Soc. Trans. 31, 169-174.
38. Neumann, D., Woods, A., Carling, D., Wallimann, T. and Schlattner, U. (2003b). Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli. Protein. Expr. Purif. 30, 230-237.
39. Osmanagic-Myers, S. and Wiche, G. (2004). Plectin-RACK1 (receptor for activated C kinase 1) scaffolding: a novel mechanism to regulate protein kinase C activity. J. Biol. Chem. 279, 18701-18710.
40. Ponticos, M., Lu, Q. L., Morgan, J. E., Hardie, D. G., Partridge, T. A. and Carling, D. (1998). Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 17, 1688-1699.
41. Rando, T. A. and Blau, H. M. (1994). Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125, 1275-1287.
42. Reipert, S., Steinböck, F., Fischer, I., Bittner, R. E., Zeöld, A. and Wiche, G. (1999). Association of mitochondria with plectin and desmin intermediate filaments in striated muscle. Exp. Cell Res. 252, 479-491.
43. Salt, I., Celler, J. W., Hawley, S. A., Prescott, A., Woods, A., Carling, D. and Hardie, D. G. (1998). AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem. J. 334, 177-187.
44. Samari, H. R., Moller, M. T., Holden, L., Asmyhr, T. and Seglen, P. O. (2005). Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins. Biochem. J. 386, 237-244.
45. Sanz, P. (2003). Snf1 protein kinase: a key player in the response to cellular stress in yeast. Biochem. Soc. Trans. 31, 178-181.
46. Schröder, R., Fürst, D. O., Klasen, C., Reimann, J., Herrmann, H. and van der Ven, P. F. (2000). Association of plectin with Z-discs is a prerequisite for the formation of the intermyofibrillar desmin cytoskeleton. Lab. Invest. 80, 455-464.
47. Scott, J. W., Hawley, S. A., Green, K. A., Anis, M., Stewart, G., Scullion, G. A. Norman, D. G. and Hardie, D. G. (2004). CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 113, 274-284.
48. Smith, F. J., Eady, R. A., Leigh, I. M., MeMillan J. R., Rugg, E. L., Kelsell, D. P., Bryant, S. P., Spurr, N. K., Geddes, J. F., Kirtschig, G. et al. (1996). Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat. Genet. 13, 450-457.
49. Stapleton, D., Mitchelhill, K. I., Gao, G., Widmer, J., Michell, B. J., Teh, T., House, C. M., Fernandez, C. S., Cox, T., Witters, L. A. et al. (1996). Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem 271, 611-614.
50. Stapleton, D., Woollatt, E., Mitchelhill, K. I., Nicholl, J. K., Fernandez, C. S., Michell, B. J., Witters, L. A., Power, D. A., Sutherland, G. R. and Kemp, B. E. (1997). AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett. 409, 452-456.
51. Stein, S. C., Woods, A., Jones, N. A., Davison, M. D. and Carling, D. (2000). The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 345, 437-443.
52. Sullivan, J. E., Carey, F., Carling, D. and Beri, R. K. (1994). Characterisation of 5′-AMP-activated protein kinase in human liver using specific peptide substrates and the effects of 5′-AMP analogues on enzyme activity. Biochem. Biophys. Res. Commun. 200, 1551-1556.
53. Thornton, C., Snowden, M. A. and Carling, D. (1998). Identification of a novel AMP-activated protein kinase beta subunit isoform thatis highly expressed in skeletal muscle. J. Biol. Chem. 273, 12443-12450.
54. Turnley, A. M., Stapleton, D., Mann, R. J., Witters, L. A., Kemp, B. E. and Bartlett, P. F. (1999). Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J. Neurochem. 72, 1707-1716.
55. Velasco, G., Geelen, M. J. and Guzman, M. (1997). Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch. Biachem. Biophys. 337, 169-175.
56. Viollet, B., Andreelli, F., Jorgensen, S. B., Perrin, C., Flamez, D., Mu, J., Wojtaszewski, J. F., Schuit, F. C., Birnbaum, M., Richter, E. et al. (2003). Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 31, 216-219.
57. Wiche, G. (1998). Role of plectin in cytoskeleton organization and dynamics. J. Cell Sci. 111, 2477-2486.
58. Wiche, G. and Baker, M. A. (1982). Cytoplasmic network arrays demonstrated by immunolocalization using antibodies to a high molecular weight protein present in cytoskeletal preparations from cultured cells. Exp. Cell Res. 138, 15-29.
59. Wiche, G., Krepler, R., Artlieb, U., Pytela, R. and Denk, H. (1983). Occurrence and immunolocalization of plectin in tissues. J. Cell Biol. 97, 887-901.
60. Winder, W. W. (2001). Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J. Appl. Physiol. 91, 1017-1028.
61. Winder, W. W., Hardie, D. G., Mustard, K. J., Greenwood, L. J., Paxton, B. E., Park, S. H., Rubink, D. S. and Taylor, E. B. (2003). Long-term regulation of AMP-activated protein kinase and acetyl-CoA carboxylase in skeletal muscle. Biochem. Soc. Trans. 31, 182-185.
62. Woods, A., Cheung, P. C., Smith, F. C., Davison, M. D., Scott, J., Beri, R. K. and Carling, D. (1996a). Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J. Biol. Chem. 271, 10282-10290.
63. Woods, A., Salt, I., Scott, J., Hardie, D. G. and Carling, D. (1996b). The alphal and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397, 347-351.
64. Woods, A., Vertommen, D., Neumann, D., Turk, R., Bayliss, J., Schlattner, U., Wallimann, T., Carling, D. and Rider, M. H. (2003). Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J. Biol. Chem. 278, 28434-28442.
65. Wu, Z., Woodring, P, J., Bhakta, K. S., Tamura, K., Wen, F., Feramisco, J. R., Karin, M., Wang, J. Y. and Puri, P. L. (2000). p38 and extracelludar signal-regulated kinases gulate the myogenic program at multiple steps. Mol. Cell. Biol. 20, 3951-3964.